StonvexLoading…
StonvexStonvexStonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Theme: healthcare · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | BMY Bristol-Myers Squibb | $57.20 | +0.51% | $116.8B | 19.5 | 2.4 | +1.8% | 53.7% | 62 |
| 1 | JNJ Johnson & Johnson | $225.35 | -2.36% | — | — | — | — | — | 69 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $1105.02 |
| -1.93% |
| — |
| — |
| — |
| — |
| — |
| 61 |
| 3 | PFE Pfizer | $26.19 | +0.19% | — | — | — | — | — | 60 |
| 4 | VTRS Viatris | $16.27 | +0.99% | — | — | — | — | — | 59 |
| 5 | MRK Merck | $118.74 | -0.96% | $293.2B | 32.8 | 4.5 | +2.9% | 78.1% | 55 |
| 6 | ZTS Zoetis | $77.71 | -0.72% | $32.8B | 12.4 | 3.4 | +2.4% | 71.8% | 46 |
| 7 | AXSM Axsome Therapeutics | $234.50 | +0.72% | $12.1B | — | 17.0 | +63.9% | 92.6% | 37 |
| 8 | RPRX RPRX | $55.78 | +2.39% | — | — | — | — | — | — |
| 9 | ELAN ELAN | $23.86 | -0.50% | — | — | — | — | — | — |